Related Experiment Video
Updated: Apr 24, 2026

Electrochemotherapy of Tumours
Published on: December 15, 2008
Electrochemotherapy in pediatrics: a systematic review
M A Formstone1, J J Neville2,3, A N Smith4
1Faculty of Medicine, University of Southampton, Southampton, UK. mf1n21@soton.ac.uk.
Insights
Electrochemotherapy (ECT) shows promise for treating pediatric tumors and vascular anomalies (VAs), with high response rates observed. Further research is needed to standardize treatment protocols and optimize safety for wider clinical use.
Area of Science:
- Pediatric Oncology
- Interventional Radiology
- Medical Technology
Background:
- Electrochemotherapy (ECT) is an emerging treatment modality.
- Evidence regarding its use in pediatric patients is limited.
- Current data on indications, efficacy, safety, and treatment parameters in children are scarce.
Purpose of the Study:
- To systematically review existing evidence on electrochemotherapy (ECT) in pediatric patients.
- To analyze indications, treatment parameters, efficacy, and safety profiles.
- To identify gaps in knowledge and areas for future research.
Main Methods:
- Systematic review adhering to PRISMA guidelines.
- Searches conducted in MEDLINE, Embase, and Cochrane Library.
- Inclusion of studies involving patients aged 18 years or younger.
- Data extraction on demographics, pathologies, electroporation parameters, agents, and outcomes.
- Risk of bias assessment using ROBINS-I.
Main Results:
- Fifteen studies involving at least 127 pediatric patients were included.
- ECT demonstrated high complete response rates (97-100%) for pediatric tumors.
- Significant volume reductions (52-100%) were observed in pediatric vascular anomalies (VAs).
- Most complications were minor, but serious adverse events were reported.
- Methodological quality was generally low due to small sample sizes and inconsistent reporting.
Conclusions:
- Electrochemotherapy (ECT) exhibits promising efficacy for pediatric tumors and VAs.
- Current evidence suggests favorable responses in children, though direct adult comparisons are limited.
- Standardized treatment guidelines and further prospective studies are crucial for clinical adoption.
- ECT may become a valuable minimally invasive option in pediatric oncology and interventional radiology.
Objectives:
To systematically review the available evidence on electrochemotherapy (ECT) in pediatric patients, focusing on indications, treatment parameters, efficacy, and safety.
Materials And Methods:
A systematic review was conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD42024575588). MEDLINE, Embase, and Cochrane Library databases were searched. Studies reporting the use of ECT in patients ≤ 18 years were included. Data extraction covered patient demographics, pathologies, electroporation parameters, agents used, and outcomes. Risk of bias was assessed using ROBINS-I.
Results:
Out of 1579 screened studies, 15 met the inclusion criteria, reporting at least 127 pediatric patients. Age was provided for 98 patients (pooled mean 8.5 years, range 0-17) and sex for 108 (58 female, 50 male). Two studies described tumors; the remainder reported vascular anomalies (VAs). Reversible electroporation with intralesional or intravenous bleomycin was the most common protocol. Complete response rates for tumors were 97-100%. Pooled volume reductions in VAs ranged from 52% to 100%. Most complications were minor, though serious events occurred, including sciatic nerve injury, disseminated intravascular coagulation, and airway compromise. Methodological quality was low, with small sample sizes and inconsistent reporting of multiple parameters.
Conclusion:
ECT is in the early stages of development but shows promising efficacy as a treatment for tumors and VAs in children. Preliminary data suggest favorable responses in children, although direct comparison with adults is limited. Further research is essential to establish standardized treatment guidelines, optimize safety, and define the role of ECT within pediatric oncology and interventional radiology. A minimum reporting dataset is proposed.
Key Points:
Question Explain the unmet need/clinical problem your study addresses. What is the current evidence regarding indications, efficacy, safety, and treatment parameters of ECT in pediatric patients? Findings Fifteen studies, including 127 children, report high response rates for tumors and VAs, but evidence is limited by small cohorts and heterogeneous reporting. Clinical relevance ECT shows promise as a minimally invasive treatment for selected pediatric tumors and VAs, but standardized protocols and large prospective studies are required before broader clinical adoption in pediatric oncology and interventional radiology.
Related Concept Videos
Electroconvulsive Therapy
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Electrochemistry: Overview
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
What is an Electrochemical Gradient?
The chemical gradient relies on differences in the abundance of a substance on the outside versus the inside of a cell and flows from areas of high to low ion concentration. In contrast, the electrical gradient revolves around an...
Electrogravimetric Analysis: Overview
To test the completeness of the...

